Serum Polyunsaturated Fatty Acids and Endometriosis

Area of Science:

• Reproductive biology
• Nutritional science
• Epidemiology

Background:

• Polyunsaturated fatty acids (PUFAs), including omega-3 (n-3) and omega-6 (n-6) types, play crucial roles in physiological processes like inflammation.
• Prior research suggests n-3 PUFAs may suppress endometriotic lesions and reduce endometriosis risk, warranting further investigation in human populations.

Purpose of the Study:

• To investigate the association between circulating levels of various polyunsaturated fatty acids (PUFAs) and the presence of endometriosis in women.
• To determine if specific PUFAs, particularly omega-3 and omega-6 fatty acids, correlate with endometriosis risk.

Main Methods:

• A cross-sectional study involving 205 women undergoing in vitro fertilization (IVF).
• Serum samples were analyzed for polyunsaturated fatty acids (PUFAs) including alpha-linolenic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid, linoleic acid, and arachidonic acid using liquid chromatography-tandem mass spectrometry.
• Multivariable logistic regression analysis was employed to assess the relationship between PUFA levels and endometriosis history.

Main Results:

• Women with higher serum levels of eicosapentaenoic acid (EPA) showed an 82% decreased likelihood of having endometriosis compared to those with lower EPA levels (OR = 0.18, 95% CI 0.04-0.78).
• Specific associations between other measured PUFAs and endometriosis were not detailed in the abstract.

Conclusions:

• Elevated circulating eicosapentaenoic acid (EPA) levels are significantly associated with a reduced prevalence of endometriosis.
• These findings suggest a potential protective role for EPA in the context of endometriosis, meriting further research into dietary and supplemental interventions.